Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Roger L. Milne(The University of Melbourne), Ching Wan Chan(Heidelberg University), Ann Smeets(German Cancer Research Center), Volker Arndt(German Cancer Research Center), Guillermo Pita(Spanish National Cancer Research Centre), Hiltrud Brauch(German Cancer Research Center), Mikael Hartman(National University of Singapore), Katazyna Durda(National University of Singapore), Jingmei Li(Genome Institute of Singapore), Hui Miao(National University of Singapore), Primitiva Menéndez‐Rodríguez(Hospital Monte Naranco), Jan Lubiński(Tumour Institute of Tuscany), Anthony J. Swerdlow(Institute of Cancer Research), Joe Dennis(University of Cambridge), Hidemi Ito(Aichi Cancer Center), Anna González‐Neira(Spanish National Cancer Research Centre), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Irene L. Andrulis(University of Toronto), Anna Jakubowska(Pomeranian Medical University), José Ignacio Arias Pérez, David Hardisson(Universidad Autónoma de Madrid), Keitaro Matsuo(Aichi Cancer Center), Sandrine Tchatchou(Mount Sinai Hospital), Ute Hamann(German Cancer Research Center), Gilian Peuteman(Pomeranian Medical University), Nick Orr(United States Department of Health and Human Services), Marie-Rose Christiaens(Pomeranian Medical University), M. Pilar Zamora(Universidad Autónoma de Madrid), Hermann Brenner(Universidad de Granada), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Hiroji Iwata(Nagoya City University), Judith S. Brand(Institute of Cancer Research), Aida Karina Dieffenbach(German Cancer Research Center), Julia A. Knight, Qin Wang(University of Cambridge), Kazuo Tajima(Kanagawa University), Barbara Burwinkel(German Cancer Research Center), Wei Yen Lim(National University of Singapore), Christa Stegmaier(Karolinska University Hospital), Alan Ashworth(University of California, San Francisco), Gord Glendon, M. Rosario Alonso(Spanish National Cancer Research Centre), Katarzyna Jaworska–Bieniek(National University of Singapore), Yon‐Dschun Ko(Johanniter-Krankenhaus Bonn), Marta Mendiola(Hospital Universitario La Paz), Manjeet K. Bolla(University of Cambridge), Minouk J. Schoemaker(Institute of Cancer Research)
Cited by 59
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k